Financing Drugs in South-East Asia - Report of the First Meeting of the WHO/SEARO Working Group on Drug Financing, Korat, Thailand, 26-28 November 1996 - Health Economics and Drugs Series No. 004
(1997; 72 pages) Ver el documento en el formato PDF
Índice de contenido
Abrir esta carpeta y ver su contenidoExecutive summary
Abrir esta carpeta y ver su contenido1. Introduction
Abrir esta carpeta y ver su contenido2. Country presentations on drug financing
Abrir esta carpeta y ver su contenido3. Korat provincial field visit
Abrir esta carpeta y ver su contenido4. Drug financing issues
Abrir esta carpeta y ver su contenido5. Country priorities for drug financing
Cerrar esta carpeta6. Priorities for work group action
Ver el documento6.1 Group A
Ver el documento6.2 Group B
Abrir esta carpeta y ver su contenido7. Conclusions and recommendations
Ver el documentoAnnex A. Agenda
Ver el documentoAnnex B. List of participants
Ver el documentoAnnex C. List of documents
Ver el documentoAnnex D. Message from Regional Director, WHO South-East Asia Region
Abrir esta carpeta y ver su contenidoAnnex E. Evaluation of the meeting. Priorities for the Working Group
 

6.2 Group B

Issue 1: How to formulate policy and guidance for cost-sharing schemes (INO, MMR, NEP, THA).

Strategies:

a) WHO should provide advice on policy as well as law and/or regulations for cost-sharing scheme(s) to countries that decide to implement this type of programme.

b) Country situation studies should be made to formulate suitable policy and guidance for cost-sharing schemes.

Issue 2: How to control drug prices on the open market (THA).

Strategies:

a) Government should formulate appropriate drug pricing policy to ensure access to essential drugs.

b) Price lists should be displayed in medical shops as should information for the general public about the price of the drugs promoted.

c) The use of generic drugs should be promoted.

d) Some countries may consider providing incentives for local drug manufacturers to reduce the prices of essential drugs.

Issue 3: How to re-supply health services and get quality drugs at the lowest possible prices (MMR, NEP).

Strategies:

a) There should be a good management information system.
b) There should be good inventory control and transportation systems.
c) Producers and suppliers should have to be prequalified.
d) There should be competitive group bidding and bargaining among prequalified suppliers.

 

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 24 abril 2012